Autismo

Allantoin (0.5–2%) is recognized by the FDA as a Category I safe and effective OTC skin protectant for diaper rash per the Skin Protectant Drug Products monograph. It promotes keratinocyte proliferation and re-epithelialization, accelerating healing of irritated skin. Multiple DailyMed-listed diaper rash products contain allantoin as an active ingredient alongside zinc oxide.

Aloe vera has been evaluated in multiple randomized clinical trials for diaper dermatitis. A 2012 RCT (Panahi et al., ScientificWorldJournal, PMC3346674) in 66 infants showed significant reduction in severity (p<0.001). A 2024 meta-analysis (n=214) confirmed a meaningful reduction in diaper dermatitis scores after topical aloe application.

Calendula officinalis ointment has been tested in multiple RCTs for diaper dermatitis and outperformed aloe vera on the number of rash sites. A 2015 Indian Journal of Medical Research RCT found it effective compared to bentonite. It is also a recognized inactive ingredient in multiple OTC diaper rash products including the Weleda Calendula Diaper Rash Cream (DailyMed NPN 80005250).

Chamomile ointment has been directly tested in a double-blind RCT (n=90 infants under 1 year) against calendula ointment for diaper rash severity over 7 days with evaluations on days 1, 3, and 7. Both demonstrated reduction in rash severity scores. Chamomile's anti-inflammatory properties are attributed to bisabolol and chamazulene.

A published RCT conducted in a neonatal ICU specifically evaluated coconut oil versus standard of care for prevention of diaper dermatitis (ScienceDirect, 2023). Coconut oil's antimicrobial and emollient properties are mechanistically plausible for diaper rash prevention and treatment; direct human trial evidence exists at the neonatal level.

Cod liver oil (5–13.56%) is recognized as a safe and effective OTC emollient and skin protectant for diaper rash by the FDA. StatPearls (NCBI Bookshelf) lists it among standard diaper dermatitis emollients. An RCT (Gozen et al., 2014, NICU population) evaluated a 40% zinc oxide with cod liver oil barrier cream formulation for neonatal diaper dermatitis.

Honey was evaluated alongside olive oil and beeswax in a clinical study (Al-Waili, Clin Microbiol Infect, 2005; 11:160-163) that reported clinical and mycological benefits in diaper dermatitis, including reduced erythema and Candida colonization. A 2023 clinical trial (NCT06134505) also assessed bee products including honey components for diaper dermatitis.

Olive oil has been evaluated in several clinical studies for diaper dermatitis. A triple-blind RCT (Sharifi-Heris et al., 2018, Dermatologic Therapy, e12731) compared olive oil and calendula ointments directly for diaper dermatitis. An earlier study in 173 children (cited in PMC3346674) showed significantly lower frequency of diaper rash with olive oil versus control.

Two clinical trials have demonstrated that dexpanthenol-containing ointment (notably Bepanthen) can help prevent and treat irritant diaper dermatitis (IDD) in infants. A 2023 real-world observational study further confirmed the efficacy and tolerability of 5% dexpanthenol ointment for IDD. It is a widely recommended first-line topical agent for this indication.

A 6-week randomized double-blind study (published in Dermatology Times, 2026) evaluated a shea butter-based emollient in diapers for pediatric erythema in the diapered area, comparing it to a petrolatum-based diaper; both showed a similar proportion of erythema-free patients. Shea butter is also a widely used inactive ingredient in OTC diaper rash creams.

Vitamin A (as retinol palmitate or via cod liver oil) is FDA conditionally approved as a skin protectant/healing agent for diaper rash. Multiple OTC diaper rash products (DailyMed) contain vitamin A as an inactive or active ingredient. Vitamin A supports epithelial regeneration and skin barrier integrity.

Vitamin D (cholecalciferol/calciferol) is FDA conditionally approved as a healing agent in diaper rash preparations, delivered via cod liver oil or as pure cholecalciferol. Multiple OTC diaper rash products (DailyMed) list vitamin D as an inactive ingredient. It supports skin barrier function and immune modulation.

Vitamin E (tocopherol/tocopheryl acetate) is FDA conditionally approved as a healing agent in diaper rash formulations and appears in multiple DailyMed OTC diaper rash products. It protects skin lipids from oxidative damage and supports epithelial barrier repair. A NICU study evaluated acetyl tocopherol as more effective than standard skin ointments for exulcerative neonatal skin lesions.

Zinc oxide is the primary FDA-recognized OTC active ingredient for treating and preventing diaper rash. It functions as a physical barrier, repelling moisture away from skin while providing mild astringent and antiseptic effects. Concentrations of 10–40% are used clinically, with higher concentrations reserved for more severe cases.

Coconut oil has been widely used as a traditional remedy for diaper rash due to its lauric acid content, which confers antimicrobial and anti-inflammatory properties. However, the most rigorous clinical trial (prospective RCT, n=149 NICU infants; ScienceDirect 2023) found that coconut oil did not prevent diaper dermatitis compared to standard of care.